Company profile: Field Medical
1.1 - Company Overview
Company description
- Provider of pulsed field ablation (PFA) technologies that use micro-bursts of energy delivered via catheter to disrupt cardiac cells without heat or cold, aiming to improve cardiac ablation treatments. Offerings include FieldForce Ventricular PFA for ventricular arrhythmia ablation, currently in first-in-human trials.
Products and services
- FieldForce™ Ventricular Pulsed Field Ablation Technology: Engineers a clinical-stage application of pulsed field ablation for ventricular arrhythmia ablation, presently in first-in-human trials to improve outcomes during cardiac ablation procedures
- Pulsed Field Ablation (PFA): Produces a nonthermal catheter-delivered micro-burst energy system that disrupts cardiac cells without heat or cold, designed to improve outcomes in cardiac ablation treatments
- Cardiac Ablation Outcomes Support: Delivers procedure-focused guidance to physicians, cardiologists, and patients during cardiac ablation procedures, helping achieve the best possible outcomes across interventions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Field Medical
Cleveland HeartLab
HQ: United States
Website
- Description: Provider of specialty clinical laboratory and disease management services focused on novel biomarker technologies and proprietary cardiovascular diagnostic tests, including inflammation testing, Cardio IQ lipid particle analysis, genetic and metabolic testing, and cardiovascular disease management, plus biomarker development R&D.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cleveland HeartLab company profile →
QT Medical
HQ: United States
Website
- Description: Provider of cloud-connected cardiac monitoring devices, including PCA 500, a compact wireless 12-lead ECG with pre-positioned single-use electrodes and HIPAA-compliant cloud data management; single-use electrode strips for quick, accurate lead placement; and Xpress ECG, an online mail-delivery at-home 12-lead ECG service with cloud uploads for remote physician review.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QT Medical company profile →
Armetheon
HQ: United States
Website
- Description: Provider of cardiovascular-focused, late-clinical stage specialty pharmaceuticals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Armetheon company profile →
Bolton Medical
HQ: United States
Website
- Description: Provider of endovascular and surgical aortic repair solutions, offering thoracic and abdominal stent-graft systems and hybrid graft devices tailored to diverse anatomies. Products include Thoraflex Hybrid, TREO, Anaconda, and relayplus with dual sheath delivery for optimal aortic navigation, precision and control, repositionable deployment, and predictable placement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bolton Medical company profile →
Annexin Pharmaceuticals
HQ: Sweden
Website
- Description: Provider of biotechnology focused on Annexin A5-based therapeutics. Develops ANXV, a human recombinant Annexin A5 that targets phosphatidylserine for acute treatment of cardiovascular diseases and is being investigated for retinal vein occlusion, cancer, and sickle cell disease. ANXV aims to protect cells, modulate immune responses, and reduce vascular inflammation and cellular stress.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Annexin Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Field Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Field Medical
2.2 - Growth funds investing in similar companies to Field Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Field Medical
4.2 - Public trading comparable groups for Field Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →